Specialists for Primary hyperoxaluria type 3
11 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.
ℹ
Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.
Report missing data- Dawn Milliner, MD, M.DRare Disease / Clinical ResearchMayo ClinicROCHESTER, MNPI×2
- Verity RawsonRare Disease / Clinical ResearchDicerna, A Novo Nordisk CompanyPI×1
- Verity Rawson, MB.CHBRare Disease SpecialistDicerna, A Novo Nordisk CompanySan Francisco, CaliforniaPI×1
- Robert Maki, MD, PhD, MD, PhDRare Disease / Clinical ResearchMemorial Sloan Kettering Cancer CenterPHILADELPHIA, PAPI×8
- John C Lieske, M.D., M.DRare Disease / Clinical ResearchMayo ClinicROCHESTER, MNPI×4
- Sarb Shergill, PhDRare Disease / Clinical ResearchDicerna Pharmaceuticals, Inc., a Novo Nordisk companyPI×1
- John Lieske, MD, M.DRare Disease / Clinical ResearchMayo ClinicROCHESTER, MNPI×1
- Alexandra Haagensen, MD, MBA, MDRare Disease / Clinical ResearchDicerna PharmaceuticalsBOSTON, MAPI×1
- Alison Armour, MDRare Disease / Clinical ResearchAstraZenecaPI×2
- Ross A Abrams, M.DRare Disease / Clinical ResearchNRG OncologyCHICAGO, ILPI×1 6
- Raúl De Lucas, Dr.Rare Disease / Clinical ResearchHospital La PazPI×1